AAAAAA
Results:
1-23
|
Results: 23
Authors:
GANTNER F
GOTZ C
GEKELER V
SCHUDT C
HATZELMANN A
Citation: F. Gantner et al., PHOSPHODIESTERASE PROFILE OF HUMAN B-LYMPHOCYTES AND THE EFFECTS OF PDE INHIBITION ON B-CELL PROLIFERATION, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 324-324
Authors:
GANTNER F
GOTZ C
GEKELER V
SCHUDT C
WENDEL A
HATZELMANN A
Citation: F. Gantner et al., PHOSPHODIESTERASE PROFILE OF HUMAN B-LYMPHOCYTES FROM NORMAL AND ATOPIC DONORS AND THE EFFECTS OF PDE INHIBITION ON B-CELL PROLIFERATION, British Journal of Pharmacology, 123(6), 1998, pp. 1031-1038
Authors:
GANTNER F
TENOR H
GEKELER V
SCHUDT C
WENDEL A
HATZELMANN A
Citation: F. Gantner et al., PHOSPHODIESTERASE PROFILES OF HIGHLY PURIFIED HUMAN PERIPHERAL-BLOOD LEUKOCYTE POPULATIONS FROM NORMAL AND ATOPIC INDIVIDUALS - A COMPARATIVE-STUDY, Journal of allergy and clinical immunology, 100(4), 1997, pp. 527-535
Authors:
GANTNER F
SCHUDT C
HATZELMANN A
Citation: F. Gantner et al., IN-VITRO DIFFERENTIATION OF HUMAN MONOCYTES - CHANGE OF PDE PROFILE AND ITS CONSEQUENCES ON SUPPRESSION OF TNF-ALPHA RELEASE BY PDE INHIBITORS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 307-307
Authors:
GANTNER F
KUSTERS S
WENDEL A
HATZELMANN A
SCHUDT C
TIEGS G
Citation: F. Gantner et al., PROTECTION FROM T-CELL-MEDIATED MURINE LIVER-FAILURE BY PHOSPHODIESTERASE INHIBITORS, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 53-60
Authors:
GANTNER F
KUPFERSCHMIDT R
SCHUDT C
WENDEL A
HATZELMANN A
Citation: F. Gantner et al., IN-VITRO DIFFERENTIATION OF HUMAN MONOCYTES TO MACROPHAGES - CHANGE OF PDE PROFILE AND ITS RELATIONSHIP TO SUPPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA RELEASE BY PDE INHIBITORS, British Journal of Pharmacology, 121(2), 1997, pp. 221-231
Authors:
HATZELMANN A
HAEFNER D
BEUME R
SCHUDT C
Citation: A. Hatzelmann et al., AUTOMATIC LEUKOCYTE DIFFERENTIATION IN BRONCHOALVEOLAR LAVAGE FLUIDS OF GUINEA-PIGS AND BROWN-NORWAY RATS, Journal of pharmacological and toxicological methods, 35(2), 1996, pp. 91-99
Authors:
AMSCHLER G
FRAHM AW
HATZELMANN A
KILIAN U
MULLERDOBLIES D
MULLERDOBLIES U
Citation: G. Amschler et al., CONSTITUENTS OF VELTHEIMIA-VIRIDIFOLIA .1. HOMOISOFLAVANONES OF THE BULBS, Planta medica, 62(6), 1996, pp. 534-539
Authors:
TENOR H
HATZELMANN A
CHURCH MK
SCHUDT C
SHUTE JK
Citation: H. Tenor et al., EFFECTS OF THEOPHYLLINE AND ROLIPRAM ON LEUKOTRIENE C-4 (LTC(4)) SYNTHESIS AND CHEMOTAXIS OF HUMAN EOSINOPHILS FROM NORMAL AND ATOPIC SUBJECTS, British Journal of Pharmacology, 118(7), 1996, pp. 1727-1735
Authors:
TENOR H
STANICIU L
WENDEL A
SCHUDT C
DJUKANOVIC R
HATZELMANN A
CHURCH MK
SHUTE JK
Citation: H. Tenor et al., CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES FROM PURIFIED HUMAN CD4-LYMPHOCYTES( AND CD8+ T), Clinical and experimental allergy, 25(7), 1995, pp. 616-624
Authors:
TENOR H
HATZELMANN A
KUPFERSCHMIDT R
STANCIU L
DJUKANOVIC R
SCHUDT C
WENDEL A
CHURCH MK
SHUTE JK
Citation: H. Tenor et al., CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOENZYME ACTIVITIES IN HUMAN ALVEOLAR MACROPHAGES, Clinical and experimental allergy, 25(7), 1995, pp. 625-633
Authors:
SCHUDT C
TENOR H
HATZELMANN A
Citation: C. Schudt et al., PDE ISOENZYMES AS TARGETS FOR ANTIASTHMA DRUGS, The European respiratory journal, 8(7), 1995, pp. 1179-1183
Authors:
SCHUDT C
HATZELMANN A
Citation: C. Schudt et A. Hatzelmann, BINDING OF [3H]ROLIPRAM AND [3H]RP73401 TO PHOSPHODIESTERASE TYPE-IV FROM HUMAN NEUTROPHILS, The FASEB journal, 9(6), 1995, pp. 1261-1261
LEUKOTRIENE SYNTHESIS INHIBITORS OF THE QUINOLINE TYPE - PARAMETERS FOR THE OPTIMIZATION OF EFFICACY
Authors:
MATZKE M
BECKERMANN B
FRUCHTMANN R
FUGMANN B
GARDINER PJ
GOOSSENS J
HATZELMANN A
JUNGE B
KELDENICH J
KOHLSDORFER C
MOHRS KH
MULLERPEDDINGHAUS R
RADDATZ S
Citation: M. Matzke et al., LEUKOTRIENE SYNTHESIS INHIBITORS OF THE QUINOLINE TYPE - PARAMETERS FOR THE OPTIMIZATION OF EFFICACY, European journal of medicinal chemistry, 30, 1995, pp. 441-451
Authors:
SCHMIDT J
HATZELMANN A
FLEISSNER S
HEIMANNWEITSCHAT I
LINDSTAEDT R
SZELENYI I
Citation: J. Schmidt et al., EFFECT OF PHOSPHODIESTERASE INHIBITION ON IL-4 AND IL-5 PRODUCTION OFTHE MURINE T(H)2-TYPE T-CELL CLONE D10.G4.1, Immunopharmacology, 30(3), 1995, pp. 191-198
Authors:
TENOR H
HATZELMANN A
WENDEL A
SCHUDT C
Citation: H. Tenor et al., IDENTIFICATION OF PHOSPHODIESTERASE-IV ACTIVITY AND ITS CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT UP-REGULATION IN A HUMAN KERATINOCYTE CELL-LINE (HACAT), Journal of investigative dermatology, 105(1), 1995, pp. 70-74
Authors:
HATZELMANN A
TENOR H
SCHUDT C
Citation: A. Hatzelmann et al., DIFFERENTIAL-EFFECTS OF NONSELECTIVE AND SELECTIVE PHOSPHODIESTERASE INHIBITORS ON HUMAN EOSINOPHIL FUNCTIONS, British Journal of Pharmacology, 114(4), 1995, pp. 821-831
Authors:
HEGEMANN L
HATZELMANN A
GREWIG S
SCHMIDT BH
Citation: L. Hegemann et al., POTENT ANTAGONISM OF CALMODULIN ACTIVITY IN-VITRO, BUT LACK OF ANTIPROLIFERATIVE EFFECTS ON KERATINOCYTES BY THE NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR MK-886, British journal of dermatology, 133(1), 1995, pp. 41-47
Authors:
HATZELMANN A
FRUCHTMANN R
MOHRS KH
RADDATZ S
MATZKE M
PLEISS U
KELDENICH J
MULLERPEDDINGHAUS R
Citation: A. Hatzelmann et al., MODE OF ACTION OF THE LEUKOTRIENE SYNTHESIS (FLAP) INHIBITOR BAY-X-1005 - IMPLICATIONS FOR BIOLOGICAL REGULATION OF 5-LIPOXYGENASE, Agents and actions, 43(1-2), 1994, pp. 64-68
Authors:
KAST R
FRUCHTMANN R
KUPFERSCHMIDT R
MOHRS KH
RADDATZ S
MULLERPEDDINGHAUS R
HATZELMANN A
Citation: R. Kast et al., ROLE OF 5-LIPOXYGENASE-ACTIVATING PROTEIN IN THE REGULATION OF 5-LIPOXYGENASE ACTIVITY IN HUMAN NEUTROPHILS, Agents and actions, 41, 1994, pp. 30000166-30000168
Authors:
HATZELMANN A
FRUCHTMANN R
MOHRS KH
RADDATZ S
MULLERPEDDINGHAUS R
Citation: A. Hatzelmann et al., CA2-STIMULATED SECRETION OF AZUROPHIL GRANULES IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES IS LARGELY MEDIATED BY ENDOGENOUSLY FORMED LEUKOTRIENEB-4( IONOPHORE A23187), Biochemical pharmacology, 48(1), 1994, pp. 31-39
Authors:
HATZELMANN A
GOOSSENS J
FRUCHTMANN R
MOHRS KH
RADDATZ S
MULLERPEDDINGHAUS R
Citation: A. Hatzelmann et al., INVERSELY-CORRELATED INHIBITION OF HUMAN 5-LIPOXYGENASE ACTIVITY BY BAY X1005 AND OTHER QUINOLINE DERIVATIVES IN INTACT-CELLS AND A CELL-FREE SYSTEM - IMPLICATIONS FOR THE FUNCTION OF 5-LIPOXYGENASE ACTIVATINGPROTEIN, Biochemical pharmacology, 47(12), 1994, pp. 2259-2268
Authors:
FRUCHTMANN R
MOHRS KH
HATZELMANN A
RADDATZ S
FUGMANN B
JUNGE B
HORSTMANN H
MULLERPEDDINGHAUS R
Citation: R. Fruchtmann et al., IN-VITRO PHARMACOLOGY OF BAY-X1005, A NEW INHIBITOR OF LEUKOTRIENE SYNTHESIS, Agents and actions, 38(3-4), 1993, pp. 188-195
Risultati:
1-23
|